Consistency with rotation Whichever site you choose, it should be part of a structured rotation plan (discussed further below) to prevent tissue damage over time
The interaction between growth hormone pathway activation and triple-receptor incretin agonism has zero clinical data supporting its safety or efficacy
Medical Writing Assistance The authors thank Manthan Mehta, Kumardeep Paul, Syed Rahman, Mansij Biswas, Arpit Jain, Jignesh Ved, from Boehringer Ingelheim (India) medical affairs for providing writing assistance for this manuscript in accordance with Good Publication Practice (GPP3) guidelines ( Authorship All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published
Market launch would follow 13 months after approval, placing patient access at Q1Q2 2028
Our findings support the investigation of lower GLP-1RA dosing in HFpEF and other cardiovascular conditions, including in non-obese patients, to expand the clinical utility of these potent drugs
